Trials / Conditions / Cognitive Deficits

Cognitive Deficits

24 registered clinical trials studyying Cognitive Deficits — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Web-based Application to Test for Long-term Cognitive Deficits in BioCog Patients NCT06716528	Charite University, Berlin, Germany	—
Withdrawn	Acupuncture Treatment for Improving Alzheimer's Dementia NCT04064021	N & S Neurology Center, A Medical Group, Inc	N/A
Recruiting	Neuromodulation and Attention Deficits in MDD NCT07111169	University of Electronic Science and Technology of China	N/A
Completed	Augmentation of Working Memory Training With Transcranial Direct Current Stimulation in Patients With Schizoph NCT03621540	University Hospital Tuebingen	N/A
Terminated	Self Treatment With an Electronic Device for Cognitive Rehabilitation in Patients With Subacute Stroke NCT06755437	Universita di Verona	N/A
Completed	Treatment of Cognitive and Negative Symptoms in Schizophrenia With N-acetylcysteine NCT02505477	University of California, Los Angeles	Phase 4
Completed	Can Cognitive Training Decrease Reactive Aggression? NCT03623477	Weill Medical College of Cornell University	N/A
Completed	Smart Autonomous Neuro-Rehabilitation System NCT02816008	Universitat Pompeu Fabra	N/A
Completed	Attentional Bias Modification Through Eye-tracker Methodology (ABMET) NCT02847793	Universidad Complutense de Madrid	N/A
Terminated	Effects of Multiple Concussions in Retired NHL Players NCT02746523	New York Institute of Technology	—
Completed	Treating Verbal Memory Deficits Following Chemotherapy for Breast Cancer NCT03017560	Northwestern University	N/A
Completed	Analysis of TCLT in TBI Patients: a Prospective, Randomized Controlled Trial NCT02393079	University of Sao Paulo General Hospital	N/A
Terminated	Improving Cognitive Aptitudes With tDCS in Patients With Multiple Sclerosis NCT02266121	University Hospital of Mont-Godinne	N/A
Completed	Cognitive Remediation Therapy Within a Secure Forensic Setting NCT02360813	Central Mental Hospital	N/A
Completed	Methylphenidate Treatment of Attention Deficits in Epilepsy NCT02178995	Kimford Jay Meador	Phase 4
Unknown	Amyloïd Load in Elderly Population: Effect of Cognitive Reserve NCT02196116	University Hospital, Bordeaux	N/A
Unknown	Hyperbaric Oxygen Therapy Can Improve Cognitive Deficits Post Low Grade Glioma Removal Surgery NCT02122042	Assaf-Harofeh Medical Center	Phase 1
Completed	Computerized Exercise Training for Cognitive Remediation in Adults With Multiple Sclerosis Treated With Gileny NCT02141022	Stony Brook University	N/A
Completed	Characterizing and Predicting Drug Effects on Cognition NCT01889602	University of Minnesota	Phase 4
Completed	Effects of Cognitive Behavioural Therapy and Exercise on Stress and Cognitive Deficits in Multiple Sclerosis NCT01763983	Sunnybrook Health Sciences Centre	N/A
Terminated	Phosphodiesterase (PDE) Inhibitors Effect on Cognitive Deficits Associated to Schizophrenia NCT01813955	University of Copenhagen	EARLY_Phase 1
Completed	Childhood Anesthesia and Cognitive Function NCT01359215	University of California, San Francisco	—
Completed	Cognitive Rehabilitation in Patients With Spina Bifida NCT01302314	Jan Stubberud	N/A
Completed	Gabapentin Treatment of Cannabis Dependence NCT00974376	The Scripps Research Institute	Phase 2